Today on DrugResearcher.com
 
GSK drug could prove unlikely saviour for Vioxx

Sangamo points finger at blood vessel growth

Bigger is better, reveals CRO survey

Raising the standard of proteomics data

Drugs moving into the clinic: 26

 
   
Related Industry News
 
Preclinical services news in brief

Encap expands Scottish drug delivery biz

ALK-Abello and Catalent to increase Grazax production

Novartis expands on Rasilez news

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Wednesday 29 August 2007 Forward to a colleague

Product Brochure

PharmatestPre-Clinical Contract Research - Free Download

Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here


Access Full Stories



GSK drug could prove unlikely saviour for Vioxx
Vioxx (rofecoxib) might have been offered a lifeline with the news that the drug could be used safely, so long as drugs such as GlaxoSmithKline's investigational dyslipidaemia compound are administered at the same... Read


Sangamo points finger at blood vessel growth
Sangamo Biosciences is engineering synthetic versions of the body's natural DNA regulators for a variety of therapeutic purposes, including against cancer, HIV/AIDS and diabetic neuropathy... Read


Bigger is better, reveals CRO survey
In terms of contract research organisations (CROs), bigger is actually better, reveals a recent Lehman Brothers survey, which offers some fresh insight into this growing industry... Read


Raising the standard of proteomics data
A new series of reporting guidelines have been developed by researchers from the European Molecular Biology Laboratory (EMBL) in an effort to aid proteomics data integration and comparison... Read


Drugs moving into the clinic: 26
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


All News Headlines for:
August | July | June

DrugResearcherProduct Brochure

A revolution in Sales Lead Generation! - Free Download

Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
Related Industry News



Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, new deals have emerged involving Hutchison MediPharma, Tripos and Clinical Data... Read


Encap expands Scottish drug delivery biz
Scottish drug delivery firm Encap has announced it has kicked off the construction of a new plant in Scotland to meet growing demand for its contract encapsulation services... Read


ALK-Abello and Catalent to increase Grazax production
ALK-Abello will be funding a new DKK 300m (€40.3m) production line dedicated to its oral grass pollen allergy vaccine at Catalent Pharma Solutions' UK facility... Read


Novartis expands on Rasilez news
24 hours after announcing EU approval of its hypertension drug Rasilez (aliskiren), Novartis has unveiled plans for a major expansion to production facilities in Switzerland... Read

Weekly comment

UK tightens Phase I guidelines

The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK. Read



KSV InstrumentsProduct Brochure

Surface Characterization by Contact Angle

From paints and coatings to biotechnology to nanotechnology, contact angle provides a quick, easy and sensitive measure of surface quality and cleanliness in research, QC and process control... Click Here

Previous Headlines



Nicholas Piramal to spin off R&D unit
Nicholas Piramal is the latest Indian pharma firm planning to spin off its new chemical entity (NCE) research unit as its pipeline is maturing... Read


MicroCal pushes ITC towards secondary screening applications
The launch of the world's fastest isothermal titration calorimeter (ITC) could herald a new dawn for a technique traditionally hampered by throughput limitations and the need for large amounts of sample... Read


Big pharma learning drug safety lessons
Big pharma is learning from past failures to improve its ability to predict drug toxicity earlier in the development process... Read


Analysts fear severe delay for Arpida antibiotic
New data have raised 'serious questions' about whether Arpida's new antibiotic will be approved by industry regulators, according to one analyst's report... Read


R&D news in brief
In a round up of the latest news in pharma research, Pfizer and Bristol-Myers Squibb have big plans for DGAT-1 in obesity and diabetes, GlaxoSmithKline is extra keen on Exelixis' anticancer drug, Takeda is talking... Read

Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com